Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
KNX-100 by Kinoxis Therapeutics for Opium (Opioid) Addiction: Likelihood of Approval
KNX-100 is under clinical development by Kinoxis Therapeutics and currently in Phase I for Opium (Opioid) Addiction. According to GlobalData,...
KNX-100 by Kinoxis Therapeutics for Unspecified Psychiatric Disorders: Likelihood of Approval
KNX-100 is under clinical development by Kinoxis Therapeutics and currently in Phase II for Unspecified Psychiatric Disorders. According to GlobalData,...
KNX-100 by Kinoxis Therapeutics for Opium (Opioid) Addiction: Likelihood of Approval
KNX-100 is under clinical development by Kinoxis Therapeutics and currently in Phase I for Opium (Opioid) Addiction. According to GlobalData,...